HanAll Biopharma Reports Second Quarter 2022 Results and Provides Business Update
/PRNewswire/ -- HanAll Biopharma (KRX: 009420.KS), a global biopharmaceutical company focusing on delivering breakthrough therapies for patients, reported...
Source: prnewswire.com